comparemela.com

Latest Breaking News On - Fusion pharmaceuticals company profile - Page 1 : comparemela.com

Fusion Pharmaceuticals (NASDAQ:FUSN) Sees Large Volume Increase

Fusion Pharmaceuticals (NASDAQ:FUSN) Sees Large Volume Increase
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
Wellington
New-zealand-general
New-zealand
Raymond-james
Nasdaq
Jennison-associates
News-ratings-for-fusion-pharmaceuticals-daily
Wellington-management-group
Institutional-trading-of-fusion-pharmaceuticals
Fusion-pharmaceuticals-inc

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives $20.25 Consensus Target Price from Analysts

Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) have earned a consensus rating of “Hold” from the fourteen analysts that are presently covering the firm, MarketBeat reports. Thirteen equities research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12 month […]

New-york
United-states
China
Canada
Raymond-james
William-blair
Leerink-partnrs
Royal-bank
Fusion-pharmaceuticals-inc
Fusion-pharmaceuticals
Fusion-pharmaceuticals-stock-performance
Institutional-investors-weigh-in-on-fusion-pharmaceuticals

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Recommendation of "Hold" by Brokerages

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Recommendation of "Hold" by Brokerages
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

China
New-york
United-states
Canada
Raymond-james
Nasdaq
Fusion-pharmaceuticals-stock-performance
York-state-common-retirement-fund
Tower-research-capital
China-universal-asset-management-co
Fusion-pharmaceuticals-company-profile
News-ratings-for-fusion-pharmaceuticals-daily

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Short Interest Down 8.3% in March

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) saw a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 7,920,000 shares, a decline of 8.3% from the February 29th total of 8,640,000 shares. Based on an average daily volume of 2,210,000 shares, the short-interest ratio […]

Canada
United-states
Leerink-partnrs
William-blair
News-ratings-for-fusion-pharmaceuticals-daily
Fusion-pharmaceuticals-stock-performance
Millennium-management
Renaissance-technologies
Institutional-trading-of-fusion-pharmaceuticals
Fusion-pharmaceuticals
Schonfeld-strategic-advisors
Fusion-pharmaceuticals-inc

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives Consensus Recommendation of "Hold" from Brokerages

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives Consensus Recommendation of "Hold" from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
Leerink-partnrs
Raymond-james
Nasdaq
Perceptive-advisors
Hermes-inc
Fusion-pharmaceuticals-price-performance
Fusion-pharmaceuticals
Sphera-funds-management
Analyst-recommendations-for-fusion-pharmaceuticals
Fusion-pharmaceuticals-inc

vimarsana © 2020. All Rights Reserved.